Stevens Capital Management LP Boosted By $799,696 Its Bio Techne (TECH) Position; Lord Abbett & Company Raised By $102.78 Million Its Mondelez Intl Cl A (MDLZ) Position

August 12, 2018 - By Jason Dias

Mondelez International, Inc. (NASDAQ:MDLZ) Logo

Lord Abbett & Company increased Mondelez Intl Inc Cl A (MDLZ) stake by 234.51% reported in 2018Q1 SEC filing. Lord Abbett & Company acquired 2.51 million shares as Mondelez Intl Inc Cl A (MDLZ)’s stock declined 11.59%. The Lord Abbett & Company holds 3.58 million shares with $149.22M value, up from 1.07M last quarter. Mondelez Intl Inc Cl A now has $61.51B valuation. The stock decreased 0.52% or $0.22 during the last trading session, reaching $41.94. About 3.88M shares traded. Mondelez International, Inc. (NASDAQ:MDLZ) has declined 14.94% since August 12, 2017 and is downtrending. It has underperformed by 27.51% the S&P500. Some Historical MDLZ News: 11/04/2018 – Mondelēz International Reports Rapid Growth of Cocoa Life Sustainable Sourcing Program; 17/04/2018 – Mondelez: Bahrain Manufacturing Plant Produces Oreo Cookies and Barni Soft Cakes for Middle East and Africa; 02/04/2018 – Mondelez Offers to Buy for Cash Up to $1B Aggregate Principal Amount in Debt Securities; 05/04/2018 – Mondelez International CDS Tightens 8 Bps, Most in 19 Months; 16/04/2018 – MONDELEZ REPORTS PRICING FOR CASH TENDER, CONSENT SOLICITATION; 07/05/2018 – MONDELEZ – 2020 NOTES TO MATURE ON MAY 7; 2020 2023 NOTES TO MATURE ON MAY 7, 2023; 2028 NOTES TO MATURE ON MAY 7, 2028; 01/05/2018 – MONDELEZ CALL ENDS; 22/04/2018 – DJ Mondelez International Inc Class , Inst Holders, 1Q 2018 (MDLZ); 16/04/2018 – Mondelēz International Announces Early Tender Results of Its Cash Tender Offer and Consent Solicitation; 06/05/2018 – Tate’s Deal Could Be Announced Monday

Stevens Capital Management Lp increased Bio Techne Corp (TECH) stake by 170.89% reported in 2018Q1 SEC filing. Stevens Capital Management Lp acquired 5,296 shares as Bio Techne Corp (TECH)’s stock rose 4.37%. The Stevens Capital Management Lp holds 8,395 shares with $1.27 million value, up from 3,099 last quarter. Bio Techne Corp now has $6.71 billion valuation. The stock increased 0.22% or $0.4 during the last trading session, reaching $178.68. About 147,611 shares traded. Bio-Techne Corporation (NASDAQ:TECH) has risen 33.83% since August 12, 2017 and is uptrending. It has outperformed by 21.26% the S&P500. Some Historical TECH News: 22/04/2018 – DJ Bio-Techne Corporation, Inst Holders, 1Q 2018 (TECH); 11/05/2018 – Bio-Techne Presenting at UBS Conference May 22; 07/05/2018 – Bio-Techne at Deutsche Bank Health Care Conference Tomorrow; 30/05/2018 – Bio-Techne Closes Above 50-Day Moving Average: Technicals; 21/03/2018 – Bio-Techne Expands RNAscope® ISH Automation – Facilitating Drug Discovery and Development; 24/04/2018 – Bio-Techne Announces New Leadership Appointment; 14/03/2018 Bio-Techne Launches MimEX™ GI, an Accessible 3-D Cell Culturing Platform for the Gastrointestinal Tract; 21/05/2018 – Bio-Techne Presenting at UBS Conference Tomorrow; 02/05/2018 – Bio-Techne Declares Dividend; 10/05/2018 – Bio-Techne at UBS Global Health Care Conference May 22

Stevens Capital Management Lp decreased Block H & R Inc (NYSE:HRB) stake by 76,105 shares to 32,894 valued at $836,000 in 2018Q1. It also reduced O Reilly Automotive Inc New (NASDAQ:ORLY) stake by 30,946 shares and now owns 1,809 shares. Orbital Atk Inc was reduced too.

Since February 13, 2018, it had 0 buys, and 2 sales for $1.44 million activity. On Friday, May 4 the insider Eansor Norman David sold $164,932. Another trade for 5,000 shares valued at $680,303 was sold by Dinarello Charles A. Kummeth Charles R. sold $1.28 million worth of stock or 8,000 shares.

Among 4 analysts covering Bio-Techne (NASDAQ:TECH), 3 have Buy rating, 0 Sell and 1 Hold. Therefore 75% are positive. Bio-Techne had 6 analyst reports since March 1, 2018 according to SRatingsIntel. On Thursday, May 3 the stock rating was maintained by Leerink Swann with “Buy”. Deutsche Bank maintained Bio-Techne Corporation (NASDAQ:TECH) rating on Thursday, March 1. Deutsche Bank has “Buy” rating and $163 target. The stock of Bio-Techne Corporation (NASDAQ:TECH) earned “Hold” rating by Deutsche Bank on Wednesday, June 27. The rating was maintained by Citigroup on Thursday, August 9 with “Buy”. The rating was maintained by Deutsche Bank on Thursday, May 3 with “Buy”.

More notable recent Bio-Techne Corporation (NASDAQ:TECH) news were published by: Nasdaq.com which released: “Nasdaq’s tech focus helps drive 11 percent profit rise” on July 25, 2018, also Cnbc.com with their article: “Nasdaq drops more than 1% as Intel and Twitter lead tech rout” published on July 27, 2018, Benzinga.com published: “Nasdaq, Tech Names Might Come Under Pressure Following Facebook’s Weak Results” on July 26, 2018. More interesting news about Bio-Techne Corporation (NASDAQ:TECH) were released by: Cnbc.com and their article: “Nasdaq hits all-time high after Amazon reaches record, Netflix rebounds well off lows” published on July 17, 2018 as well as Nasdaq.com‘s news article titled: “Q2 Earnings Preview: 3 Hot Tech Stocks to Buy” with publication date: July 16, 2018.

Investors sentiment increased to 1.32 in Q1 2018. Its up 0.34, from 0.98 in 2017Q4. It is positive, as 14 investors sold TECH shares while 89 reduced holdings. 53 funds opened positions while 83 raised stakes. 35.01 million shares or 1.47% less from 35.53 million shares in 2017Q4 were reported. Rice Hall James And Associates Llc holds 0.11% or 19,186 shares. Schwab Charles Investment reported 247,403 shares. Prudential Fincl has 74,954 shares for 0.02% of their portfolio. Wendell David Assocs stated it has 1,500 shares or 0.04% of all its holdings. Rmb Ltd holds 0.01% or 1,628 shares. Victory Cap Management invested 0.01% in Bio-Techne Corporation (NASDAQ:TECH). Atlantic Tru Gp Ltd Liability accumulated 375 shares. Oakbrook Invests Ltd Liability Com stated it has 0.03% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Virginia Retirement Et Al invested 0% of its portfolio in Bio-Techne Corporation (NASDAQ:TECH). Retirement System Of Alabama holds 48,467 shares or 0.04% of its portfolio. New York-based Tower Capital Limited (Trc) has invested 0.04% in Bio-Techne Corporation (NASDAQ:TECH). Duncker Streett Company has invested 0% in Bio-Techne Corporation (NASDAQ:TECH). D E Shaw & Com reported 30,581 shares or 0.01% of all its holdings. Amer Century Companies holds 0.06% or 409,028 shares. Us Bankshares De invested in 54,848 shares or 0.03% of the stock.

More news for Mondelez International, Inc. (NASDAQ:MDLZ) were recently published by: Globenewswire.com, which released: “MondelÄ“z International to Host Investor Day on September 7” on August 10, 2018. Seekingalpha.com‘s article titled: “Credit Suisse updates on Mondelez International” and published on July 30, 2018 is yet another important article.

Since February 16, 2018, it had 2 buys, and 3 sales for $1.03 billion activity. On Tuesday, February 27 the insider PELTZ NELSON sold $284.87M. $45.54M worth of Mondelez International, Inc. (NASDAQ:MDLZ) was bought by MAY PETER W on Friday, March 9. Weber Hubert had sold 10,931 shares worth $478,668. 2,000 shares were bought by BUNCH CHARLES E, worth $87,800.

Lord Abbett & Company decreased Discover Finl Svcs Com (NYSE:DFS) stake by 103,088 shares to 2.10M valued at $151.33 million in 2018Q1. It also reduced Voya Finl Inc Com (NYSE:VOYA) stake by 40,800 shares and now owns 52,200 shares. Abbvie Inc Com (NYSE:ABBV) was reduced too.

Investors sentiment increased to 1.04 in Q1 2018. Its up 0.04, from 1 in 2017Q4. It increased, as 46 investors sold MDLZ shares while 390 reduced holdings. 101 funds opened positions while 352 raised stakes. 1.06 billion shares or 0.62% less from 1.07 billion shares in 2017Q4 were reported. Moreover, Hartford Fincl Inc has 1.07% invested in Mondelez International, Inc. (NASDAQ:MDLZ) for 50,621 shares. Archford Strategies Limited Liability Com owns 897 shares. Hotchkis & Wiley Cap Lc stated it has 5.62M shares. Pettee holds 0.13% in Mondelez International, Inc. (NASDAQ:MDLZ) or 4,911 shares. Pinnacle Assoc Ltd stated it has 0.2% of its portfolio in Mondelez International, Inc. (NASDAQ:MDLZ). The Delaware-based Ashford Cap Mngmt has invested 0.07% in Mondelez International, Inc. (NASDAQ:MDLZ). Moreover, Jfs Wealth Ltd Liability Corporation has 0.02% invested in Mondelez International, Inc. (NASDAQ:MDLZ). Profund Advsr Ltd Company invested 0.19% in Mondelez International, Inc. (NASDAQ:MDLZ). Joel Isaacson And Ltd Limited Liability Company reported 11,079 shares or 0.08% of all its holdings. Hanson Mcclain, California-based fund reported 1,421 shares. Invest Of Virginia Limited Liability Co holds 0.09% in Mondelez International, Inc. (NASDAQ:MDLZ) or 9,164 shares. Cranbrook Wealth Mngmt Limited Liability Company stated it has 0% in Mondelez International, Inc. (NASDAQ:MDLZ). Bankshares Of New York Mellon holds 17.16M shares. Riverhead Management Limited Liability Corp holds 0.05% or 26,598 shares. Pillar Pacific Capital Mngmt Ltd Llc, a California-based fund reported 12,459 shares.

Among 8 analysts covering Mondelez International (NASDAQ:MDLZ), 7 have Buy rating, 0 Sell and 1 Hold. Therefore 88% are positive. Mondelez International had 9 analyst reports since April 16, 2018 according to SRatingsIntel. The firm has “Buy” rating by DZ Bank given on Friday, July 27. As per Monday, July 23, the company rating was maintained by JP Morgan. The company was maintained on Wednesday, May 2 by Stifel Nicolaus. On Monday, April 16 the stock rating was maintained by Credit Suisse with “Buy”. Morgan Stanley maintained the shares of MDLZ in report on Wednesday, May 2 with “Overweight” rating. The stock has “Buy” rating by UBS on Thursday, July 26. On Tuesday, April 24 the stock rating was maintained by RBC Capital Markets with “Buy”. The firm has “Buy” rating by UBS given on Wednesday, June 20.

Mondelez International, Inc. (NASDAQ:MDLZ) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts